Clinical stage biopharmaceutical company focused on development of novel therapeutics for cancer and age-related macular degeneration.
- Year invested 2014
- Investment Stage Early
- Sectors
- Investment Status Current
- Associated Team
- Website traconpharma.com/
- Company Status IPO/Public (NASDAQ: TCON)